Bevacizumab Versus Ranibizumab in the Treatment of Macular Edema Due to Retinal Vein Occlusion: 6-Month Results of the CRAVE Study

Rajagopal Rithwick; Shah Gaurav K.; Blinder Kevin J.; Altaweel Michael; Eliott Dean; Wee Raymond; Cooper Blake; Walia Harpreet; Smith Bradley; Joseph Daniel P.

首页> 外文期刊>Ophthalmic surgery, lasers & imaging retina >Bevacizumab Versus Ranibizumab in the Treatment of Macular Edema Due to Retinal Vein Occlusion: 6-Month Results of the CRAVE Study

【24h】

Bevacizumab Versus Ranibizumab in the Treatment of Macular Edema Due to Retinal Vein Occlusion: 6-Month Results of the CRAVE Study

机译：贝伐单抗与雷珠单抗对视网膜静脉阻塞引起的黄斑水肿的治疗：CRAVE研究的6个月结果

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

BACKGROUND AND OBJECTIVE: To compare efficacy of monthly treatment with bevacizumab or ranibizumab for macular edema due to retinal vein occlusion.

机译：背景与目的：比较贝伐单抗或兰尼单抗每月治疗因视网膜静脉阻塞引起的黄斑水肿的疗效。

著录项

来源
《Ophthalmic surgery, lasers & imaging retina》 |2015年第8期|共7页
作者
Rajagopal Rithwick; Shah Gaurav K.; Blinder Kevin J.; Altaweel Michael; Eliott Dean; Wee Raymond; Cooper Blake; Walia Harpreet; Smith Bradley; Joseph Daniel P.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类眼科学;
关键词

相似文献

外文文献
中文文献
专利

1. Bevacizumab Versus Ranibizumab in the Treatment of Macular Edema Due to Retinal Vein Occlusion: 6-Month Results of the CRAVE Study [J] . Rajagopal Rithwick, Shah Gaurav K., Blinder Kevin J., Ophthalmic surgery, lasers & imaging retina . 2015,第8期

机译：贝伐单抗与雷珠单抗对视网膜静脉阻塞引起的黄斑水肿的治疗：CRAVE研究的6个月结果
2. A randomized, double masked, controlled study of efficacy and safety of intravitreal ranibizumab versus bevacizumab in subjects with macular edema secondary to branch retinal vein occlusion. BRANVO Study. [J] . Taraprasad Das, Raja Narayanan, Bhavik Panchal, Investigative ophthalmology & visual science . 2014,第13期

机译：玻璃体腔内雷珠单抗与贝伐单抗治疗继发于视网膜分支静脉阻塞的黄斑水肿的疗效和安全性的随机，双掩蔽，对照研究。 BRANVO研究。
3. Real-world outcomes with ranibizumab 0.5 mg treatment in French patients with visual impairment due to macular edema secondary to central retinal vein occlusion: 6-month results from the 24-month BOREAL-CRVO study [J] . Srour Mayer, Glacet Agnes, Girmens Jean-Francois, Investigative ophthalmology & visual science . 2017,第8期

机译：Ranibizumab的现实世界成果0.5毫克治疗法国患者视觉损伤由于Marular Dema继发于中央视网膜静脉闭塞：24个月的Boreal-CRVO研究结果为6个月的结果
4. Automated segmentation of intraretinal cystoid macular edema for retinal 3D OCT images with macular hole [C] . Li Zhang, Weifang Zhu, Fei Shi, IEEE International Symposium on Biomedical Imaging . 2015

机译：视网膜内囊样黄斑水肿的自动分割，用于视网膜黄斑裂孔3D OCT图像
5. Retinal Vascular Blood Flow in Patients with Retinal Vein Occlusions [D] . Koch, Rachelle Elif. 2020

机译：视网膜静脉闭塞患者的视网膜血管血流
6. A 6-month subject-masked randomized controlled study to assess efficacy of dexamethasone as an adjunct to bevacizumab compared with bevacizumab alone in the treatment of patients with macular edema due to central or branch retinal vein occlusion [O] . Raj K Maturi, Vincent Chen, Dan Raghinaru, 2014

机译：为期6个月的受试者掩盖的随机对照研究评估地塞米松作为贝伐单抗的辅助治疗与单独贝伐单抗相比在治疗因中央或分支视网膜静脉阻塞而引起的黄斑水肿患者中的疗效
7. Clinical Effectiveness of Intravitreal Therapy With Ranibizumab vs Aflibercept vs Bevacizumab for Macular Edema Secondary to Central Retinal Vein Occlusion [O] . Philip Hykin, A. Toby Prevost, Joana C. Vasconcelos, 2019

机译：含有Ranibizumab的宫腔治疗的临床疗效与阿昔普菌与中央视网膜静脉闭塞的黄斑水肿对贝伐自烟草

Bevacizumab Versus Ranibizumab in the Treatment of Macular Edema Due to Retinal Vein Occlusion: 6-Month Results of the CRAVE Study

摘要

著录项

相似文献

相关主题

期刊订阅